WHO ICTRP trial
A clinical trial to evaluate the safety, tolerability, and pharmacokinetics of…
NL-OMON51974 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON51974 |
|---|---|
| Public title | A clinical trial to evaluate the safety, tolerability, and pharmacokinetics of single and multiple ascending oral doses of LEO 153339 in healthy subjects |
| Scientific title | A clinical trial to evaluate the safety, tolerability, and pharmacokinetics of single and multiple ascending oral doses of LEO 153339 in healthy subjects - A single and multiple ascending dose trial of LEO 153339 in healthy adults |
| Primary sponsor | Leo Pharma A/S |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | Psoriasis Psoriasis;Psoriasis |
| Interventions | Part 1 The study compound will be given once on Day 1. The table below shows the planned dose levels for each group. The doses of later groups can be adjusted. For example because the study compound had more or less effect than was… |
| Registration date | Jan 26, 2022 |
| Target size | 134 |
| Secondary IDs | 2020-005748-51;NL77226.056.21 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: